Eli Lilly targets India as global supply chain hub for blockbuster drugs
The drugmaker plans to turn India into a global export hub using a billion-dollar investment. This follows surging Mounjaro sales and plans for new treatments.
Insights:
Eli Lilly and Company announced on February 17, 2026, its plan to establish India 
IN as a hub for its global supply chain. This initiative is part of a previously committed $1 billion investment in the contract manufacturing sector in India. The United States 
US-based pharmaceutical firm aims to export locally produced drugs worldwide, leveraging India's contract-manufacturing capacity to reshape its supply and distribution for key products.
IN as a hub for its global supply chain. This initiative is part of a previously committed $1 billion investment in the contract manufacturing sector in India. The United States US-based pharmaceutical firm aims to export locally produced drugs worldwide, leveraging India's contract-manufacturing capacity to reshape its supply and distribution for key products.
